A time-resolved proteomic and diagnostic map characterizes COVID-19 disease progression and predicts outcome
Por um escritor misterioso
Descrição
medRxiv - The Preprint Server for Health Sciences
Frontiers Hallmarks of Severe COVID-19 Pathogenesis: A Pas de Deux Between Viral and Host Factors
Proteomics of extracellular vesicles in plasma reveals the characteristics and residual traces of COVID-19 patients without underlying diseases after 3 months of recovery
IJMS, Free Full-Text
Immunohematologic Biomarkers in COVID-19: Insights into Pathogenesis, Prognosis, and Prevention
Temporal dynamics of the host molecular responses underlying severe COVID-19 progression and disease resolution - eBioMedicine
A multiplex protein panel assay for severity prediction and outcome prognosis in patients with COVID-19: An observational multi-cohort study - eClinicalMedicine
Frontiers Proteomic Approaches to Unravel Mechanisms of Antibiotic Resistance and Immune Evasion of Bacterial Pathogens
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease progression and predicts outcome
Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patients - ScienceDirect
Plasma Proteomics Identify Biomarkers and Pathogenesis of COVID-19 - ScienceDirect
Clinical and Laboratory Diagnosis of SARS-CoV-2, the Virus Causing COVID-19
A Multi-omics Longitudinal Study Reveals Alteration of the Leukocyte Activation Pathway in COVID-19 Patients
High‐resolution serum proteome trajectories in COVID‐19 reveal patient‐specific seroconversion
Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection - eBioMedicine
de
por adulto (o preço varia de acordo com o tamanho do grupo)
